Greenberg Traurig has hired Ashok Lalwani and Shih-Chi Pan as shareholders to drive cross-border work in Singapore.
“The firm has been hiring many leading lawyers who can deliver solutions for our clients and respond to their growing interest in the complex, cross-border work taking place and connecting the Americas, London and Europe, the Middle East and Asia, and Singapore has become a key hub,” Richard A Rosenbaum, Greenberg Traurig’s executive chairman, told Asia Business Law Journal.
He said building an even stronger India practice while increasing the firm’s talent in Singapore was a compelling strategy and Lalwani was a prime example of this strategy,
Lalwani joined the firm’s Singapore office on 5 November from Baker McKenzie, where he served for 23 years as head of international capital markets, Asia-Pacific, and for 14 years as global head of the India practice.
He was an industry-leading lawyer operating throughout Asia with deep experience in mergers and acquisitions, capital market transactions and corporate advisory work, said Rosenbaum.
In his previous role, Lalwani focused on public and private international securities offerings and cross-border M&A, including representing non-US-based companies in transactions involving US federal securities laws.
In November 2024, he co-led a team advising Bangkok Bank, Bank of Ayudhya, Krung Thai Bank and Standard Chartered Bank (Thai) on Thailand’s inaugural issuance of up to THB30 billion (USD925 million) worth of sustainability-linked bonds (SLBs).
This issuance marked Asia’s first sovereign SLB and the inaugural series under Thailand’s Public Debt Management Office (PDMO) plan to issue THB130 billion in SLBs during fiscal year 2025.
Meanwhile, Pan joined the firm from Goodwin, where she was a partner for nine years. She has more 15 years of experience advising investment funds and their portfolio companies on cross-border transactions, including mergers and acquisitions (such as leveraged buyouts, stock and asset sales, and joint ventures), as well as early and late-stage venture capital and growth equity investments.
Pan specialises in cross-border deals for private equity and venture capital firms and their portfolio companies, working across a range of industries including technology, life sciences, health care, financial services and advanced manufacturing.
